1
Home
Companies

Mauna Kea Technologies

Mauna Kea Technologies
Leadership team

Mr. Alexandre Loiseau Ph.D. (Co-Founder, CEO & Chairman)

Mr. Nicolas Bouvier (HR Director)

Mr. John S. Soto (Chief Operating Officer)

Products/ Services
Biotechnology, Medical, Medical Device
Number of Employees
50 - 100
Headquarters
Paris, Ile-de-France, France
Established
2000
Revenue
5M - 20M
Traded as
EPA:MKEA
Social Media
URL
https://www.maunakeatech.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.
History

Mauna Kea Technologies is a French, publicly traded medical device company that was founded in 2000 by Jacques Souquet and Alexandra Golby. The company was recognized in 2006 as one of the 30 most innovative firms in Europe by MIT Technology Review. In 2011, the company received marketing clearance from the FDA for use of their Cellvizio technology. The Cellvizio system has since been used in cancer detection and diagnosis in the United States and other countries around the world.

Mission
Mauna Kea Technologies mission is to improve the lives of patients by providing solutions to enhance accuracy, early detection, and treatment of cancer and other diseases.
Vision
Mauna Kea Technologies vision is to be the leader in revolutionary optical biopsy solutions in order to diagnose and monitor disease earlier and more accurately.
Key Team

Mr. Frederic Banegas Ph.D. (Chief Technology Officer)

Mr. François Lacombe Ph.D. (Chief Scientific Officer)

Mr. Bruno Villaret (Global Director of Sales)

Mr. Daryl Donatelli (VP of Global Marketing & U.S. Sales)

Ms. Aline Criton Ph.D. (Chief Clinical & Regulatory Affairs Officer)

Recognition and Awards
Mauna Kea Technologies has been awarded the CES Innovation Award, Medical Futures Innovation Award, and Medical Device of the Year in 2011 from Frost & Sullivan.
References

https://en.wikipedia.org/wiki/Mauna_Kea_Technologies

https://in.investing.com/equities/mauna-kea-technologies-sas

https://finance.yahoo.com/quote/MKEA.PA/profile?p=MKEA.PA

https://www.crunchbase.com/organization/mauna-kea

https://www.maunakeatech.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Mauna Kea Technologies
Leadership team

Mr. Alexandre Loiseau Ph.D. (Co-Founder, CEO & Chairman)

Mr. Nicolas Bouvier (HR Director)

Mr. John S. Soto (Chief Operating Officer)

Products/ Services
Biotechnology, Medical, Medical Device
Number of Employees
50 - 100
Headquarters
Paris, Ile-de-France, France
Established
2000
Revenue
5M - 20M
Traded as
EPA:MKEA
Social Media
URL
https://www.maunakeatech.com